Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

aspire pharma ltd - levocetirizine dihydrochloride - oral tablet - 5mg

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

somex pharma - levocetirizine dihydrochloride - oral tablet - 5mg

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - levocetirizine dihydrochloride - oral tablet - 5mg

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - levocetirizine dihydrochloride - oral tablet - 5mg

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - levocetirizine dihydrochloride - oral tablet - 5mg

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - levocetirizine dihydrochloride - oral tablet - 5mg

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

genesis pharmaceuticals ltd - levocetirizine dihydrochloride - oral tablet - 5mg

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - levocetirizine dihydrochloride - oral tablet - 5mg

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

bristol laboratories ltd - levocetirizine dihydrochloride - oral tablet - 5mg

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - levocetirizine dihydrochloride (unii: sod6a38aga) (levocetirizine - unii:6u5ea9rt2o) - levocetirizine dihydrochloride 0.5 mg in 1 ml - levocetirizine dihydrochloride oral solution is indicated for the relief of symptoms associated with perennial allergic rhinitis in children 6 months to 2 years of age. levocetirizine dihydrochloride oral solution is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 months of age and older. the use of levocetirizine dihydrochloride is contraindicated in: patients with known hypersensitivity to levocetirizine or any of the ingredients of levocetirizine dihydrochloride, or to cetirizine. observed reactions range from urticaria to anaphylaxis [see adverse reactions (6.2)] . patients with end-stage renal disease (clcr <10 ml/min) and patients undergoing hemodialysis children 6 months to 11 years of age with impaired renal function risk summary available data from published literature and postmarketing experience with levocetirizine use in pregnant women are insufficient to identify any drug-associated risks of miscarriage, birth defects,